Floatz logo

e7 tcr-t cells

Throat Cancer

Christian HinrichsCell therapyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Throat Cancer cohort.

Asset / SponsorPhaseRating
Cetuximab
M.D. Anderson Cancer Center
Phase 1CC
Valproic Acid
M.D. Anderson Cancer Center
Phase 1CC
Temsirolimus
M.D. Anderson Cancer Center
Phase 1CC
Trastuzumab Deruxtecan
AstraZeneca
D

Same molecule, other indications

e7 tcr-t cells is also rated in:

cervical carcinomaDormant
B
Indicative ·
60 / 100
View asset →
oropharynx cancerDormant
B
Indicative ·
60 / 100
View asset →
vulva cancerDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →